These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 16423606

  • 1. Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome.
    Bannink EM, Raat H, Mulder PG, de Muinck Keizer-Schrama SM.
    J Pediatr; 2006 Jan; 148(1):95-101. PubMed ID: 16423606
    [Abstract] [Full Text] [Related]

  • 2. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
    Bannink EM, van Sassen C, van Buuren S, de Jong FH, Lequin M, Mulder PG, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):265-73. PubMed ID: 19200215
    [Abstract] [Full Text] [Related]

  • 3. Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome.
    Davenport ML.
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S91-7. PubMed ID: 16735135
    [Abstract] [Full Text] [Related]

  • 4. Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome.
    van Pareren YK, Duivenvoorden HJ, Slijper FM, Koot HM, Drop SL, de Muinck Keizer-Schrama SM.
    Horm Res; 2005 Jul; 63(5):238-44. PubMed ID: 15900109
    [Abstract] [Full Text] [Related]

  • 5. [Optimizing estrogen treatment in Turner syndrome].
    Ságodi L, Sólyom E.
    Orv Hetil; 2003 Mar 23; 144(12):563-8. PubMed ID: 12723527
    [Abstract] [Full Text] [Related]

  • 6. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep 23; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 7. Growth promoting treatment normalizes speech frequency in Turner syndrome.
    Andersson-Wallgren G, Ohlsson AC, Albertsson-Wikland K, Barrenäs ML.
    Laryngoscope; 2008 Jun 23; 118(6):1125-30. PubMed ID: 18354336
    [Abstract] [Full Text] [Related]

  • 8. Psychosocial functioning, self-perception and body image and their auxologic correlates in growth hormone and oestrogen-treated young adult women with Turner syndrome.
    Lagrou K, Froidecoeur C, Verlinde F, Craen M, De Schepper J, François I, Massa G, Belgian Study Group of Paediatric Endocrinology.
    Horm Res; 2006 Jun 23; 66(6):277-84. PubMed ID: 16946621
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences.
    Bannink EM, van der Palen RL, Mulder PG, de Muinck Keizer-Schrama SM.
    Horm Res; 2009 Jun 23; 71(6):343-9. PubMed ID: 19506392
    [Abstract] [Full Text] [Related]

  • 10. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
    Binder G, Trebar B, Baur F, Schweizer R, Ranke MB.
    Clin Endocrinol (Oxf); 2008 Apr 23; 68(4):567-72. PubMed ID: 17973940
    [Abstract] [Full Text] [Related]

  • 11. Treatment outcome in Turner syndrome.
    Parvin M, Roche E, Costigan C, Hoey HM.
    Ir Med J; 2004 Jan 23; 97(1):12, 14-5. PubMed ID: 15055914
    [Abstract] [Full Text] [Related]

  • 12. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z, Cetinkaya E, Darendeliler F, Vidinlisan S, Bas F, Bideci A, Demirel F, Darcan S, Buyukgebiz A, Yildiz M, Berberoglu M, Bundak R.
    Clin Endocrinol (Oxf); 2008 May 23; 68(5):769-72. PubMed ID: 17980015
    [Abstract] [Full Text] [Related]

  • 13. Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone.
    Taback SP, Van Vliet G.
    BMC Pediatr; 2011 May 29; 11():49. PubMed ID: 21619701
    [Abstract] [Full Text] [Related]

  • 14. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.
    Massa G, Heinrichs C, Verlinde S, Thomas M, Bourguignon JP, Craen M, François I, Du Caju M, Maes M, De Schepper J, Belgian Study Group for Pediatric Endocrinology.
    J Clin Endocrinol Metab; 2003 Sep 29; 88(9):4168-74. PubMed ID: 12970282
    [Abstract] [Full Text] [Related]

  • 15. Optimizing estrogen replacement treatment in Turner syndrome.
    Rosenfield RL, Perovic N, Devine N, Mauras N, Moshang T, Root AW, Sy JP.
    Pediatrics; 1998 Aug 29; 102(2 Pt 3):486-8. PubMed ID: 9685449
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone (GH) treatment reduces peripheral thyroid hormone action in girls with Turner syndrome.
    Susperreguy S, Miras MB, Montesinos MM, Mascanfroni ID, Muñoz L, Sobrero G, Silvano L, Masini-Repiso AM, Coleoni AH, Targovnik HM, Pellizas CG.
    Clin Endocrinol (Oxf); 2007 Oct 29; 67(4):629-36. PubMed ID: 17666093
    [Abstract] [Full Text] [Related]

  • 17. Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients.
    Costa AM, Lemos-Marini SH, Baptista MT, Morcillo AM, Maciel-Guerra AT, Guerra G.
    J Bone Miner Metab; 2002 Oct 29; 20(5):294-7. PubMed ID: 12203035
    [Abstract] [Full Text] [Related]

  • 18. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome.
    Reiter EO, Blethen SL, Baptista J, Price L.
    J Clin Endocrinol Metab; 2001 May 29; 86(5):1936-41. PubMed ID: 11344188
    [Abstract] [Full Text] [Related]

  • 19. Health-related quality of life and coping strategies of children after treatment of a malignant bone tumor: a 5-year follow-up study.
    Koopman HM, Koetsier JA, Taminiau AH, Hijnen KE, Bresters D, Egeler RM.
    Pediatr Blood Cancer; 2005 Oct 15; 45(5):694-9. PubMed ID: 15924359
    [Abstract] [Full Text] [Related]

  • 20. Adult height in Turkish patients with Turner syndrome without growth hormone treatment.
    Bereket A, Turan S, Elçioğlu N, Hacihanefioğlu S, Memioğlu N, Baş F, Bundak R, Darendeliler F, Günöz H, Saka N, Ercan O, Arslanoğlu I, Işgüven P, Yildiz M, Can S, Ozerkan E, Coker M, Darcan S, Ozkan B, Orbak Z, Oztaş S, Palandüz S, Sezgin I, Atabek E, Erkul I, Erdoğan G.
    Turk J Pediatr; 2008 Oct 15; 50(5):415-7. PubMed ID: 19102043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.